Boardroom Alpha
Meeting calendar
NVEC · Annual meeting · Thursday, August 6, 2026

Nve Corp

7 nominees · 3 ballot items.

Elect seven directors (Proposal 1); advisory approval of named executive officer compensation (say-on-pay) (Proposal 2); and ratification of Boulay PLLP as independent registered public accounting firm for fiscal 2027 (Proposal 3).

Market cap
$626M
1Y TSR
+73.7%
Board grade
C+
Record date
Jun 12, 2026
Filing
DEF 14A
Meeting concluded · Aug 6, 2026

Follow how the vote landed and what changed on Nve Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Board of Directors

    ManagementBoard: FOR

    Elect seven directors to serve until the 2027 Annual Meeting: Daniel A. Baker, Peter G. Eames, Terrence W. Glarner, Patricia M. Hollister, James W. Bracke, Kelly Wei, and Carolyn W. Valentine.

  2. 2

    Advisory Resolution Regarding Named Executive Officer Compensation

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the company’s named executive officers as disclosed in the proxy statement.

    More detail

    This proposal asks shareholders to cast a non-binding, advisory vote approving the company’s named executive officer (NEO) compensation as disclosed in the proxy statement, including tables and narrative discussion. Management is seeking shareholder approval as a measure of shareholder support for its pay practices and to provide feedback that the Compensation Committee will consider when setting future NEO compensation. The company’s disclosed compensation framework emphasizes alignment with performance—base salary, performance-based incentives tied to income from operations, modest stock option grants, and limited perks—designed to reward growth and profitability while limiting dilution and excessive pay. The proposal is advisory and will not bind the Board, but the Compensation Committee treats the result as important guidance, noting strong prior shareholder support (97% approval in 2025) as evidence of alignment with shareholders. Company-specific context includes a pay-for-performance link where incentives are based on income from operations (capturing revenue and cost control), no change-in-control severance arrangements, and limited equity awards, which the Board points to as prudent governance practices. Management’s recommendation to vote FOR is justified by the Compensation Committee as consistent with compensation philosophy and with demonstrated shareholder support historically. For analysts evaluating governance risk, the advisory vote is an indicator of shareholder sentiment but does not create contractual entitlements; a negative vote would prompt the Committee to engage with shareholders and potentially adjust plan design. The Board’s stated rationale balances retaining and motivating executives with shareholder protection against excessive pay, and it will consider the advisory result when making future compensation decisions.

  3. 3

    Ratification of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of Boulay PLLP as the company’s independent registered public accounting firm to audit fiscal 2027 financial statements.

Director elections

Nominees on the ballot7

Independent
Tenure on this board
2.2 yrs
Carolyn W. Valentine
Independent
Tenure on this board
New nominee
Ownership

Top institutional holders10

Latest 13F quarter
1Silverberg Bernstein Capital Management LLC1.4%69,220$7M
2ISTHMUS PARTNERS, LLC1.0%49,980$5M
3Merrion Investment Management Co, LLC0.9%43,265$5M
4NEW YORK STATE COMMON RETIREMENT FUND0.3%12,126$1M
5Cambridge Investment Research Advisors, Inc.0.2%9,144$956K
6Apollon Wealth Management, LLC0.2%8,837$924K
7ALPS ADVISORS INC0.2%7,436$777K
8Kings Path Partners LLC0.2%7,405$774K
9PRINCIPAL FINANCIAL GROUP INC0.1%4,971$520K
10Y-Intercept (Hong Kong) Ltd0.1%4,690$490K
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Nve Corp 2026 annual meeting?
Nve Corp (NVEC) holds its 2026 annual shareholder meeting on Thursday, August 6, 2026.
What is the record date for the Nve Corp 2026 meeting?
The record date for the Nve Corp 2026 meeting is Friday, June 12, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Nve Corp's 2026 meeting?
The board is presenting 7 director nominees at the Nve Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Nve Corp 2026 meeting?
Shareholders will vote on 3 proposals at the Nve Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer